Metraipolis › archive › dc_ffb16fab47ea

The impact of chemoimmunotherapy on primary cold agglutinin disease and Waldenström macroglobulinemia-associated cold agglutinin syndrome — Europe PMC PMID:42755913

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42755913
DOI: 10.3389/fmed.2026.1926130
License (as archived): solo-consultazione
Archived: 2026-10-16T04:00:53.000Z
SHA-256 of the archived text: 724d56bdec21be2174ba163a11f60765dd8e455cfac373100be6d6c8947e89ec
Stable URL of this page: https://metraipolis.com/documento/dc_ffb16fab47ea

How to cite

The impact of chemoimmunotherapy on primary cold agglutinin disease and Waldenström macroglobulinemia-associated cold agglutinin syndrome — Europe PMC PMID:42755913 — Europe PMC (en), https://europepmc.org/article/MED/42755913 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ffb16fab47ea (Metraipolis archive dc_ffb16fab47ea, sha256 724d56bdec21be2174ba163a11f60765dd8e455cfac373100be6d6c8947e89ec)

BibTeX

@misc{dcffb16fab47ea,
  title = {The impact of chemoimmunotherapy on primary cold agglutinin disease and Waldenström macroglobulinemia-associated cold agglutinin syndrome — Europe PMC PMID:42755913},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42755913},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ffb16fab47ea; sha256 724d56bdec21be2174ba163a11f60765dd8e455cfac373100be6d6c8947e89ec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42755913. Agents can read the archived copy with the MCP tool read_document.